Perspective

Unsere Perspektive

  • Critical Illness 101 Series

    Von Steve Rowley|December 03, 2014|English

    We have all heard the saying that “The whole is greater than the sum of its parts.” This is as true for insurance as it is for anything else. Whether one is developing a first Critical Illness insurance product, selling to the consumer, underwriting...

    Lesen Sie mehr
  • Diabetes and Life Insurance - Crossing the Divide

    Von Andres Webersinke |November 13, 2014|English

    Diabetes is on track to become the world’s seventh leading cause of death by 2030, according to the World Health Organization. Diabetes already affects several hundred million people and worryingly, younger people are increasingly being diagnosed...

    Lesen Sie mehr
  • Critical Illness As a Supplement to Limited Medical Plans

    Von Steve Rowley|November 04, 2014|English

    The nature of Critical Illness insurance makes it a perfect supplement for countless insurance products. Detractors may argue that Critical Illness insurance isn't as comprehensive as core products, such as Health Insurance or Disability Income insurance...

    Lesen Sie mehr
  • Critical Illness As a Supplement to Accident

    Von Steve Rowley|October 19, 2014|English

    One of the more popular forms of supplemental insurance today is Accident insurance. Purchasers understand that, even with underlying health insurance, they will often be exposed to large out-of-pocket expenses after such common medical issues as sprains,...

    Lesen Sie mehr
  • Good Prognosis for Critical Illness Insurance Market - Survey

    Von Steve Rowley|September 16, 2014|English

    The critical illness insurance sector is in good health. That sounds like a contradiction in terms; in fact it’s the conclusion of our 13th annual Critical Illness Insurance Market Survey undertaken by Gen Re in conjunction with the National Association...

    Lesen Sie mehr
  • DIY Genetic Testing - Is the Genie Out of the Bottle?

    Von Dr. John Cummins|August 19, 2014|English

    The first sequence of the human genome was made publicly available in 2003. It took international laboratories collaborating over 10 years to complete, at a cost of around US$3 billion. Technological advances now mean that a human genome can be sequenced...

    Lesen Sie mehr